Bone Cell Growth Regulation by Runx2/Cbfa1
Bone Cell Growth Regulation by Runx2/Cbfa1
批准号:
8586146
负责人:
Andre J. Van Wijnen
金额:
$35.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2016-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Skeletal regenerative medicine promises to mitigate age-related bone loss and support fracture healing but requires manipulation of biological properties of osteogenic progenitor cells. Osteogenic cells must sustain their phenotype during lineage-expansion yet undergo a number of mitotic cell cycles to generate the requisite number of cells for proper tissue-organization. The proposed study will examine fundamental mechanisms that ensure cells retain a post-mitotic molecular memory of the bone phenotype. The central hypothesis of our study is that key mRNAs for osteogenic factors are passed on to daughter cells during mitosis as a component of a non-genomic epigenetic mechanism and that selected microRNAs (miRs) attenuate the translation of these transmitted mRNAs. Our hypothesis is based on a robust set of preliminary data showing that the osteogenic master regulator Runx2 is controlled by mitotic miRs in osteoblastic cell lines. Based on these and other preliminary data, we will (i) characterize mitotic mRNAs and cognate miRs that suppress expression of lineage-specific factors in osteogenic cells, (ii) examine miR dependent changes in protein expression and lineage-plasticity in proliferating osteoblasts, and (iii) characterize the physiological role of mitosis-related miRs during skeletal development in vivo. Validation of this concept would (i) establish a major new dimension in cell cycle regulation, (ii) reveal a previously unrecognized function for miRs during mitosis, (iii) define a novel molecular mechanism for biological control of gene expression in lineage-committed cells, and (iv) identify specific miRs that are transmitted to osteogenic progeny cells upon mitosis ('mito-miRs'). From a molecular therapeutic perspective, these miRs permit generation of epigenomic agents that control cellular inheritance by targeting cell fate determining factors which mediate mesenchymal stem cell expansion and differentiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bone Cell Growth Regulation by Runx2/Cbfa1
-
批准号:6619987
-
项目类别:
-
资助金额:$29.34万
-
财政年份:2003
-
负责人:Andre J. Van Wijnen
-
依托单位:
Bone Cell Growth Regulation by Runx2/Cbfa1
-
批准号:6898940
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2003
-
负责人:Andre J. Van Wijnen
-
依托单位:
Molecular Control of Bone Formation
-
批准号:9548158
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2003
-
负责人:Andre J. Van Wijnen
-
依托单位:
Bone Cell Growth Regulation by Runx2/Cbfa1
-
批准号:6805608
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2003
-
负责人:Andre J. Van Wijnen
-
依托单位:
Bone Cell Growth Regulation by Runx2/Cbfa1
-
批准号:7068564
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2003
-
负责人:Andre J. Van Wijnen
-
依托单位:
Bone Cell Growth Regulation by Runx2/Cbfa1
-
批准号:7245925
-
项目类别:
-
资助金额:$26.08万
-
财政年份:2003
-
负责人:Andre J. Van Wijnen
-
依托单位:
Bone Cell Growth Regulation by Runx2/Cbfa1
-
批准号:7934489
-
项目类别:
-
资助金额:$41.12万
-
财政年份:2003
-
负责人:Andre J. Van Wijnen
-
依托单位:
Bone Cell Growth Regulation by Runx2/Cbfa1
-
批准号:8530154
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2003
-
负责人:Andre J. Van Wijnen
-
依托单位:
Bone Cell Growth Regulation by Runx2/Cbfa1
-
批准号:8911776
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2003
-
负责人:Andre J. Van Wijnen
-
依托单位:
Bone Cell Growth Regulation by Runx2/Cbfa1
-
批准号:7739099
-
项目类别:
-
资助金额:$41.02万
-
财政年份:2003
-
负责人:Andre J. Van Wijnen
-
依托单位:
Bone Cell Growth Regulation by Runx2/Cbfa1
-
批准号:8727255
-
项目类别:
-
资助金额:$35.06万
-
财政年份:2003
-
负责人:Andre J. Van Wijnen
-
依托单位:
Bone Cell Growth Regulation by Runx2/Cbfa1
-
批准号:8248526
-
项目类别:
-
资助金额:$37.01万
-
财政年份:2003
-
负责人:Andre J. Van Wijnen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
面向Cell-Free网络的协同虚拟化与动态传输
-
批准号:62371367
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈健
-
依托单位:
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
-
批准号:82373069
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:何美芳
-
依托单位:
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:宋贾俊
-
依托单位:
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
-
批准号:82273886
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:原永芳
-
依托单位:
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2022
-
负责人:黄红艳
-
依托单位:
基于Cell-SELEX 的磁珠富集技术与LAMP 联合构建的梅毒螺旋体核酸检测方法及其临床应用
-
批准号:2021JJ30609
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:肖勇健
-
依托单位: